Sulfonylureas

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC A10BB
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector SULFONYLUREAS

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 8641 3248 5393
Unadjusted prevalence (%) 3.32 2.21 4.77
Mean age at first event (years) 59.42 59.85 59.16

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.67 [2.32, 3.08] 9.7e-43 3094
15 years 0.02 2.81 [2.52, 3.15] 2.8e-73 2405
5 years 0.00 2.83 [2.53, 3.17] 8.9e-74 667
1 year 0.00 2.25 [1.79, 2.83] 4.2e-12 101

Correlations

Index endpoint: SULFONYLUREAS – Sulfonylureas
GWS hits:

Survival analyses between endpoints

Plot

before Sulfonylureas
after Sulfonylureas

loading spinner Loading survival analyses plot